Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol).
Protein microspheres are of particular utility in the field of drug delivery. A novel, completely aqueous, process of microsphere fabrication has been devised based on controlled phase separation of protein from water-soluble polymers such as polyethylene glycols. The fabrication process results in the formation of spherical microparticles with narrow particle size distributions. Cooling of preheated human insulin-poly(ethylene glycol)-water solutions results in the facile formation of insulin particles. To map out the supersaturation conditions conducive to particle nucleation and growth, we determined the temperature- and concentration-dependent boundaries of an equilibrium liquid-solid phase separation. The kinetics of formation of microspheres were followed by dynamic and continuous-angle static light scattering techniques. The presence of PEG at a pH that was close to the protein's isoelectric point resulted in rapid nucleation and growth. The time elapsed from the moment of creation of a supersaturated solution and the detection of a solid phase in the system (the induction period, t(ind)) ranged from tens to several hundreds of seconds. The dependence of t(ind) on supersaturation could be described within the framework of classical nucleation theory, with the time needed for the formation of a critical nucleus (size <10 nm) being much longer than the time of the onset of particle growth. The growth was limited by cluster diffusion kinetics. The interfacial energies of the insulin particles were determined to be 3.2-3.4 and 2.2 mJ/m(2) at equilibrium temperatures of 25 and 37 degrees C, respectively. The insulin particles formed as a result of the process were monodisperse and uniformly spherical, in clear distinction to previously reported processes of microcrystalline insulin particle formation.
Bromberg
Lev
L
Epic Therapeutics Inc., Norwood, MA 02062, USA.
Rashba-Step
Julia
J
Scott
Terrence
T
D001672:Biocompatible Materials / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers; D004339:Drug Compounding; D016503:Drug Delivery Systems; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000737:chemistry / Q000494:pharmacology*; D007700:Kinetics; D008027:Light; D008855:Microscopy, Electron, Scanning; D008863:Microspheres; D010316:Particle Size; D004364:Pharmaceutical Preparations; D011092:Polyethylene Glycols / Q000737:chemistry*; D011100:Polyglycolic Acid / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry; D011506:Proteins; D012542:Scattering, Radiation; D012995:Solubility; D012996:Solutions; D013499:Surface Properties; D013696:Temperature; D013997:Time Factors; D014867:Water / Q000737:chemistry
D001672:Biocompatible Materials; D004337:Drug Carriers; D007328:Insulin; D004364:Pharmaceutical Preparations; D011108:Polymers; D011506:Proteins; D012996:Solutions; D014867:Water; D011100:Polyglycolic Acid; D011092:Polyethylene Glycols